Citi lowered the firm’s price target on Kenvue (KVUE) to $20 from $22 and keeps a Neutral rating on the shares. The firm updated models in the beverages and home and personal care group. Citi favors non-alcoholic beverages to the personal care and beverage alcohol sectors. The analyst’s top pick is now Celsius (CELH), followed by Monster Beverage (MNST) and Coca-Cola (KO).
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KVUE:
- Kenvue Stock (KVUE) Up after CEO Met Health Secretary to Kick Tylenol Off Autism Report
- Kenvue lobbied RFK Jr. not to cite Tylenol as autism cause, WSJ reports
- Buy Rating on Kenvue, Inc. Amidst Minimal Legal Risks and Overreaction to Tylenol Concerns
- Kenvue price target lowered to $23 from $25 at Evercore ISI
- Kenvue Inc put buyer realizes 365% same-day gains